2010•Annals of HematologyOpen access

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

Francisco Javier Peñalver, Alberto Álvarez‐Larrán, José L. Díez‐Martín, Laura Gallur, Isidro Jarque, Dolores Caballero, Joaquín Diaz‐Mediavilla, Rosalía Bustelos, María Jesús Fernández‐Aceñero, José Rafael Cabrera, on behalf of the Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA

Open full text 69 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 69 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Rituximab, Medicine, Refractory (planetary science), Autoimmune hemolytic anemia, Internal medicine, Splenectomy, Gastroenterology, Rash